Search

Your search keyword '"Habermann, Thomas M."' showing total 2,375 results

Search Constraints

Start Over You searched for: Author "Habermann, Thomas M." Remove constraint Author: "Habermann, Thomas M."
2,375 results on '"Habermann, Thomas M."'

Search Results

1. Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

2. Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

3. Defining primary refractory large B-cell lymphoma

4. Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment

5. Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP

6. Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

7. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

8. Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy

11. Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma

12. Contributors

13. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

14. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

15. Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

18. Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

19. Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

22. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

23. Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

25. Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes

26. Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy

27. Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy

28. Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low–Tumor Burden Follicular Lymphoma

29. High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course

32. PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts

35. Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

36. Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.

38. Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

41. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

42. Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

43. DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

44. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023

45. Evaluation of the International Prognostic Score (IPS‐7) and a Simpler Prognostic Score (IPS‐3) for advanced Hodgkin lymphoma in the modern era

47. Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial

48. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.

49. A genome-wide association study of marginal zone lymphoma shows association to the HLA region.

50. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Catalog

Books, media, physical & digital resources